You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

MAXAIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Maxair patents expire, and what generic alternatives are available?

Maxair is a drug marketed by Bausch and is included in two NDAs.

The generic ingredient in MAXAIR is pirbuterol acetate. There are three drug master file entries for this compound. Additional details are available on the pirbuterol acetate profile page.

US Patents and Regulatory Information for MAXAIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bausch MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 020014-001 Nov 30, 1992 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MAXAIR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ⤷  Try a Trial ⤷  Try a Trial
Bausch MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ⤷  Try a Trial ⤷  Try a Trial
Bausch MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 020014-001 Nov 30, 1992 ⤷  Try a Trial ⤷  Try a Trial
Bausch MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MAXAIR

See the table below for patents covering MAXAIR around the world.

Country Patent Number Title Estimated Expiration
U.S.S.R. 503518 ⤷  Try a Trial
Australia 578915 ⤷  Try a Trial
Japan S60323 ⤷  Try a Trial
Philippines 9617 PYRIDINE SYMPATHOMIMETIC BRONCHODILATORS AND INTERMEDIATES THEREFOR ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 8501880 ⤷  Try a Trial
Belgium 880981 ⤷  Try a Trial
Switzerland 541560 Préparation de dérivés de la pyridine trisubstituée ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.